Evaluating Safety of T4090 Eye Drops in Ocular Hypertension and Glaucoma Patients

Unknown Phase 1,Phase 2 NCT05389267

Study Description

This study aims to assess the safety of T4090 eye drops for patients dealing with ocular hypertension or glaucoma without making any assumptions or recommendations. It involves a safety evaluation of the treatment, without claiming any results or solutions.

Study Details

Registry ID:: NCT05389267
Conditions:: Glaucoma, Ocular Hypertension
Phase:: Phase 1,Phase 2
Target Enrollment:: 120 participants
Start Date:: July 5, 2022
Age Range:: 18–999 years
Healthy Volunteers:: No

Study Locations (1 site)

Dr EL-HARAZI
Glendale, CaliforniaUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →